Cargando…
Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
OBJECTIVES: Spinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD) is a polyglutamine disorder with no current disease-modifying treatment. Conformational changes in mutant ataxin-3 trigger different pathogenic cascades, including reactive oxygen species (ROS) generation; however, the clini...
Autores principales: | de Assis, Adriano M., Saute, Jonas Alex Morales, Longoni, Aline, Haas, Clarissa Branco, Torrez, Vitor Rocco, Brochier, Andressa Wigner, Souza, Gabriele Nunes, Furtado, Gabriel Vasata, Gheno, Tailise Conte, Russo, Aline, Monte, Thais Lampert, Castilhos, Raphael Machado, Schumacher-Schuh, Artur, D’Avila, Rui, Donis, Karina Carvalho, de Mello Rieder, Carlos Roberto, Souza, Diogo Onofre, Camey, Suzi, Leotti, Vanessa Bielefeldt, Jardim, Laura Bannach, Portela, Luis Valmor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611390/ https://www.ncbi.nlm.nih.gov/pubmed/28979235 http://dx.doi.org/10.3389/fneur.2017.00485 |
Ejemplares similares
-
State biomarkers for Machado Joseph disease: Validation, feasibility
and responsiveness to change
por: Furtado, Gabriel Vasata, et al.
Publicado: (2019) -
Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
por: Miglorini, Elaine Cristina, et al.
Publicado: (2022) -
Bayesian models as a unified approach to estimate relative risk (or prevalence ratio) in binary and polytomous outcomes
por: Torman, Vanessa Bielefeldt Leotti, et al.
Publicado: (2015) -
The progression rate of spinocerebellar ataxia type 2 changes with stage of disease
por: Monte, Thais Lampert, et al.
Publicado: (2018) -
Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal
por: Schuler-Faccini, Lavínia, et al.
Publicado: (2014)